During the past decade, Vivantes Klinikum Am Urban Klinik für Innere Medizin Hämatologie und Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vivantes Klinikum Am Urban Klinik für Innere Medizin Hämatologie und Onkologie" are "Breast Cancer" (1 trials) and "Relapsed or Refractory Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Vivantes Klinikum Am Urban Klinik für Innere Medizin Hämatologie und Onkologie" in a lesser frequency.

Most popular intervention types in "Vivantes Klinikum Am Urban Klinik für Innere Medizin Hämatologie und Onkologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Fulvestrant" (1 trials), "Inavolisib" (1 trials), "Lenalidomide" (1 trials), "Mosunetuzumab" (1 trials) and "Palbociclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vivantes Klinikum Am Urban Klinik für Innere Medizin Hämatologie und Onkologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Vivantes Klinikum Am Urban Klinik für Innere Medizin Hämatologie und Onkologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Vivantes Klinikum Am Urban Klinik für Innere Medizin Hämatologie und Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vivantes Klinikum Am Urban Klinik für Innere Medizin Hämatologie und Onkologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".